Arthur M. Cohen & Associates’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Arthur M. Cohen & Associates’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-988	Closed	-$313K	–	146
2023 Q4	$313K	Sell	988 -222	-18%	-$43.2K	0.07%	104
2023 Q3	$205K	Sell	1,210 -765	-39%	-$144K	0.05%	121
2023 Q2	$428K	Hold	1,975	–	–	0.11%	89
2023 Q1	$359K	Buy	1,975 +332	+20%	+$63.5K	0.1%	92
2022 Q4	$323K	Buy	1,643 +548	+50%	+$118K	0.09%	99
2022 Q3	$246K	Buy	+1,095	New	+$222K	0.07%	110

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Arthur M. Cohen & Associates's KRTX Position: Q1 2024 in Review

Arthur M. Cohen & Associates sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 988 shares — an estimated $313K sold.

Arthur M. Cohen & Associates first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $428K in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Arthur M. Cohen & Associates reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Arthur M. Cohen & Associates sold 988 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $313K.
Arthur M. Cohen & Associates first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
Arthur M. Cohen & Associates's Karuna Therapeutics, Inc. Common Stock position peaked at $428K in Q2 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Arthur M. Cohen & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.